Levi & Korsinsky Investigates Possible Securities Fraud Violations by Inari Medical, Inc. (NARI)
New York, NY (ACCESSWIRE) – March 25, 2024 – Levi & Korsinsky is currently investigating potential securities fraud violations involving Inari Medical, Inc. (NASDAQ:NARI), which were announced by the company following their Q4 and full-year 2023 financial results. Inari Medical disclosed that they had received a civil investigative demand from the US Department of Justice regarding payments made to healthcare professionals under the federal Anti-Kickback Statute and Civil False Claims Act. As a result of this news, shares of Inari Medical, Inc. fell by over 7% on February 29, 2024.
For more information or to participate in the investigation, visit this link: https://zlk.com/pslra-1/inari-medical-inc-lawsuit-submission-form?prid=72526&wire=1. You can also reach out to Joseph E. Levi, Esq., via email at jlevi@levikorsinsky.com or by phone at (212) 363-7500.
Levi & Korsinsky, a nationally-recognized securities litigation firm, has a successful track record of advocating for shareholders and securing significant settlements over the past two decades. They have experience in handling complex cases and have a history of achieving favorable outcomes for aggrieved shareholders.
